| Title | Advances in Dual Diagnosis |
| Abbreviation | Adv. Dual Diagn. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Psychiatry and Mental Health (Q3) |
| h-index | 16 |
| Overall Rank/Ranking | 15026 |
| SCImago Journal Rank (SJR) | 0.354 |
| Impact Score | 0.86 |
| Publisher | Emerald Group Publishing Ltd. |
| Country | United Kingdom |
| ISSN | 17570972, 20428324 |
| Best Quartile | Q3 |
| Coverage History | 2008-2025 |
Advances in Dual Diagnosis is a journal covering the technologies/fields/categories related to Psychiatry and Mental Health (Q3). It is published by Emerald Group Publishing Ltd.. The overall rank of Advances in Dual Diagnosis is 15026. According to SCImago Journal Rank (SJR), this journal is ranked 0.354. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 16. The best quartile for this journal is Q3.
The ISSN of Advances in Dual Diagnosis journal is 17570972, 20428324. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Advances in Dual Diagnosis is cited by a total of 54 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Advances in Dual Diagnosis is 0.86, which is computed in 2025 as per its definition. Advances in Dual Diagnosis IF is increased by a factor of 0.04 and approximate percentage change is 4.88% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Advances in Dual Diagnosis is 0.86. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.86 |
| 2023 | 0.82 |
| 2022 | 1.00 |
| 2021 | 0.97 |
| 2020 | 0.68 |
| 2019 | 0.48 |
| 2018 | 0.81 |
| 2017 | 0.37 |
| 2016 | 0.84 |
| 2015 | 0.69 |
| 2014 | 0.16 |
Advances in Dual Diagnosis has an h-index of 16. It means 16 articles of this journal have more than 16 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Advances in Dual Diagnosis is 17570972, 20428324. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Advances in Dual Diagnosis is 15026. According to SCImago Journal Rank (SJR), this journal is ranked 0.354. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.354 |
| 2023 | 0.248 |
| 2022 | 0.226 |
| 2021 | 0.281 |
| 2020 | 0.265 |
| 2019 | 0.250 |
| 2018 | 0.295 |
| 2017 | 0.210 |
| 2016 | 0.242 |
| 2015 | 0.245 |
| 2014 | 0.143 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 15026 |
| 2023 | 17602 |
| 2022 | 17855 |
| 2021 | 15382 |
| 2020 | 16053 |
| 2019 | 16150 |
| 2018 | 13865 |
| 2017 | 16882 |
| 2016 | 15580 |
| 2015 | 15315 |
| 2014 | 21275 |
Advances in Dual Diagnosis is published by Emerald Group Publishing Ltd.. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2008-2025. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Advances in Dual Diagnosis is Adv. Dual Diagn.. This abbreviation ('Adv. Dual Diagn.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Psychiatry and Mental Health (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Advances in Dual Diagnosis latest impact IF is 0.86. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 1.00 (2022) and 0.16 (2014), respectively, in the last 11 years. Moreover, its average IS is 0.7 in the previous 11 years.
The Advances in Dual Diagnosis has an SJR (SCImago Journal Rank) of 0.354, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 0.354 in 2024 and the lowest being 0.143 in 2014. Furthermore, the average SJR of the Advances in Dual Diagnosis over the previous 11-year period stands at 0.7.
The latest h-index of the Advances in Dual Diagnosis is 16.
The Advances in Dual Diagnosis is published by the Emerald Group Publishing Ltd., with its country of publication being the United Kingdom.
The Advances in Dual Diagnosis is currently ranked 15026 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 13865 in 2018 and its lowest position of 21275 in 2014.
The standard ISO4 abbreviation for the Advances in Dual Diagnosis is Adv. Dual Diagn..
Advances in Dual Diagnosis is classified as a journal that the Emerald Group Publishing Ltd. publishes.
The Advances in Dual Diagnosis encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Advances in Dual Diagnosis is assigned the following International Standard Serial Numbers (ISSN): 17570972, 20428324.
The best quartile for the Advances in Dual Diagnosis is Q3 (2024).
The Advances in Dual Diagnosis coverage history can be summarized as follows: 2008-2025.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| European Union Politics | journal | 1953 | SAGE Publications Ltd | 79 | 3.71 |
| Historia | journal | 22470 | Universidade Estadual Paulista | 9 | 0.16 |
| Qualitative Research | journal | 1300 | SAGE Publications Ltd | 101 | 6.77 |
| Journal of Applied Business Research | journal | 26260 | Clute Institute | 33 | 0.17 |
| Materials Research | journal | 15597 | Universidade Federal de Sao Carlos | 75 | 1.40 |
| Journal of Sociolinguistics | journal | 4415 | Wiley-Blackwell Publishing Ltd | 68 | 2.14 |
| Howard Journal of Communications | journal | 14582 | Taylor and Francis Ltd. | 42 | 1.27 |
| Rinsan Shikenj Oha/Journal of the Hokkaido Forest Products Research Institute | journal | 29148 | Hoikkaido Forest Products Research Institute | 4 | 0.00 |
| Biological Procedures Online | journal | 5232 | BioMed Central Ltd | 51 | 4.00 |
| Epigenetics | journal | 4304 | Taylor and Francis Ltd. | 117 | 3.37 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.86 |
| 2023 | 0.82 |
| 2022 | 1.00 |
| 2021 | 0.97 |
| 2020 | 0.68 |
| 2019 | 0.48 |
| 2018 | 0.81 |
| 2017 | 0.37 |
| 2016 | 0.84 |
| 2015 | 0.69 |
| 2014 | 0.16 |